These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14812645)

  • 1. Clinical evaluation of dicumarinyl derivatives with a metabolic study of the radioactively labeled anticoagulants in animals.
    HAUSNER EP; SHAFER CL; CORSON M; JOHNSON O; TRUJILLO T; LANGHAM W
    Circulation; 1951 Feb; 3(2):171-81. PubMed ID: 14812645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
    SCARRONE LA; BECK DF; WRIGHT IS
    Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
    [No Abstract]   [Full Text] [Related]  

  • 4. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with thrombocid, dicumarol and tromexan in the prophylaxis and treatment of thrombosis and embolism].
    BRETTLER A; HOEPFNER W
    Z Urol; 1951; 44(7):464-79. PubMed ID: 14867571
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
    TOOHEY M
    Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experiences with the anticoagulant, ethyl biscoumacetate (N.N.R.).
    BARKER NW; ESTES JE; MANN FD
    Proc Staff Meet Mayo Clin; 1951 Apr; 26(9):162-7. PubMed ID: 14827945
    [No Abstract]   [Full Text] [Related]  

  • 8. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
    DELLA SANTA R
    Helv Med Acta Suppl; 1952; 19(28):1-64. PubMed ID: 13044126
    [No Abstract]   [Full Text] [Related]  

  • 10. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT.
    POLLER L
    Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histological examination of the effect of high doses of dicumarol and tromexan on animal liver and other organs].
    HUECK O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1951; 212(3-4):302-10. PubMed ID: 14820118
    [No Abstract]   [Full Text] [Related]  

  • 13. Tromexan and dicoumarol.
    ILLINGWORTH DG
    Br Med J; 1951 Sep; 2(4732):646-8. PubMed ID: 14869675
    [No Abstract]   [Full Text] [Related]  

  • 14. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 15. ANTICOAGULANTS.
    BEAMISH RE
    Can Med Assoc J; 1965 Jul; 93(1):33-4. PubMed ID: 14313622
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of the pharmacology of oral anticoagulants.
    Coon WW; Willis PW
    Clin Pharmacol Ther; 1970; 11(3):312-36. PubMed ID: 4192279
    [No Abstract]   [Full Text] [Related]  

  • 17. PHARMACODYNAMICS OF PARENTERAL AND ORAL ANTICOAGULANTS.
    FREMONT RE
    Angiology; 1964 Mar; 15():152-62. PubMed ID: 14130384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic value of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C; SIGUIER F; WELTI JJ; COBLENTZ B; NEDEY ; BREYNAERT
    Sem Hop; 1951 May; 27(35):1511-22. PubMed ID: 14866256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological properties and physiological effects of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C; SIGUIER F; WELTI JJ; PIETTE M; POULLAIN P; PHILIPPON J
    Sem Hop; 1951 May; 27(35):1505-11. PubMed ID: 14866255
    [No Abstract]   [Full Text] [Related]  

  • 20. Dicumarol, coumadin, marcumar and tromexan; comparative study of their action on the clot as registered by the thrombelastogram.
    ESCUDERO J; McDEVITT E; WRIGHT IS
    Circulation; 1959 Sep; 20():405-12. PubMed ID: 13820773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.